Real-World Evidence: What Can You Say to Payers and Patient Advocates?
This presentation, part 3 of 3, provides insights into the types of communications that the FDA has indicated are or are not permissible, and the uncertainties that still remain.
This presentation, part 3 of 3, provides insights into the types of communications that the FDA has indicated are or are not permissible, and the uncertainties that still remain.
This podcast, part two of a two-part series, discusses practical tips on how to incorporate cybersecurity into your own practices and devices.
This MAPS podcast details what medical device cybersecurity is and why you should care.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.